| 0.7 |
2.7 |
GO:0098582 |
innate vocalization behavior(GO:0098582) |
| 0.6 |
3.2 |
GO:1902228 |
mammary gland fat development(GO:0060611) positive regulation of macrophage colony-stimulating factor signaling pathway(GO:1902228) positive regulation of response to macrophage colony-stimulating factor(GO:1903971) positive regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903974) positive regulation of microglial cell migration(GO:1904141) |
| 0.5 |
3.2 |
GO:0035026 |
leading edge cell differentiation(GO:0035026) |
| 0.5 |
2.7 |
GO:0002415 |
immune response in mucosal-associated lymphoid tissue(GO:0002386) immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
| 0.5 |
2.1 |
GO:1990926 |
short-term synaptic potentiation(GO:1990926) |
| 0.5 |
1.5 |
GO:0045578 |
negative regulation of B cell differentiation(GO:0045578) |
| 0.4 |
1.3 |
GO:0046013 |
regulation of T cell homeostatic proliferation(GO:0046013) |
| 0.3 |
1.6 |
GO:1904158 |
axonemal central apparatus assembly(GO:1904158) |
| 0.3 |
2.0 |
GO:0034436 |
glycoprotein transport(GO:0034436) |
| 0.3 |
0.3 |
GO:0090214 |
spongiotrophoblast layer developmental growth(GO:0090214) |
| 0.3 |
0.3 |
GO:0006338 |
chromatin remodeling(GO:0006338) |
| 0.3 |
2.3 |
GO:0042699 |
follicle-stimulating hormone signaling pathway(GO:0042699) |
| 0.2 |
1.1 |
GO:0044208 |
'de novo' AMP biosynthetic process(GO:0044208) |
| 0.2 |
0.6 |
GO:0033242 |
regulation of cellular amine catabolic process(GO:0033241) negative regulation of cellular amine catabolic process(GO:0033242) negative regulation of the force of heart contraction(GO:0098736) regulation of arginine catabolic process(GO:1900081) negative regulation of arginine catabolic process(GO:1900082) regulation of citrulline biosynthetic process(GO:1903248) negative regulation of citrulline biosynthetic process(GO:1903249) negative regulation of cellular amino acid biosynthetic process(GO:2000283) |
| 0.2 |
0.8 |
GO:1904425 |
negative regulation of GTP binding(GO:1904425) |
| 0.2 |
1.4 |
GO:0072675 |
multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
| 0.2 |
2.1 |
GO:0034201 |
response to oleic acid(GO:0034201) |
| 0.2 |
0.6 |
GO:0021812 |
neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
| 0.2 |
1.8 |
GO:0002158 |
osteoclast proliferation(GO:0002158) |
| 0.2 |
0.8 |
GO:0061056 |
sclerotome development(GO:0061056) |
| 0.1 |
0.4 |
GO:0071106 |
coenzyme A transport(GO:0015880) coenzyme A transmembrane transport(GO:0035349) adenosine 3',5'-bisphosphate transmembrane transport(GO:0071106) AMP transport(GO:0080121) |
| 0.1 |
0.6 |
GO:0032072 |
plasmacytoid dendritic cell activation(GO:0002270) regulation of restriction endodeoxyribonuclease activity(GO:0032072) negative regulation of apoptotic cell clearance(GO:2000426) |
| 0.1 |
0.8 |
GO:0097327 |
response to antineoplastic agent(GO:0097327) |
| 0.1 |
0.6 |
GO:2000174 |
regulation of pro-T cell differentiation(GO:2000174) positive regulation of pro-T cell differentiation(GO:2000176) |
| 0.1 |
1.6 |
GO:0090232 |
positive regulation of spindle checkpoint(GO:0090232) |
| 0.1 |
0.8 |
GO:0015692 |
lead ion transport(GO:0015692) |
| 0.1 |
1.2 |
GO:0003025 |
regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
| 0.1 |
1.3 |
GO:0007168 |
receptor guanylyl cyclase signaling pathway(GO:0007168) |
| 0.1 |
0.4 |
GO:0006663 |
platelet activating factor biosynthetic process(GO:0006663) |
| 0.1 |
1.7 |
GO:0048251 |
elastic fiber assembly(GO:0048251) |
| 0.1 |
0.8 |
GO:0070649 |
polar body extrusion after meiotic divisions(GO:0040038) formin-nucleated actin cable assembly(GO:0070649) |
| 0.1 |
5.7 |
GO:0003301 |
physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.1 |
0.3 |
GO:1904899 |
regulation of hepatic stellate cell proliferation(GO:1904897) positive regulation of hepatic stellate cell proliferation(GO:1904899) hepatic stellate cell proliferation(GO:1990922) |
| 0.1 |
1.2 |
GO:0045218 |
zonula adherens maintenance(GO:0045218) |
| 0.1 |
0.4 |
GO:0003357 |
noradrenergic neuron differentiation(GO:0003357) N-terminal peptidyl-lysine acetylation(GO:0018076) |
| 0.1 |
0.4 |
GO:0050915 |
sensory perception of sour taste(GO:0050915) |
| 0.1 |
0.4 |
GO:0014912 |
negative regulation of smooth muscle cell migration(GO:0014912) |
| 0.1 |
0.6 |
GO:0043461 |
proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
| 0.1 |
0.7 |
GO:0019805 |
quinolinate biosynthetic process(GO:0019805) |
| 0.1 |
0.9 |
GO:0018916 |
nitrobenzene metabolic process(GO:0018916) |
| 0.1 |
0.3 |
GO:1903568 |
negative regulation of protein localization to cilium(GO:1903565) regulation of protein localization to ciliary membrane(GO:1903567) negative regulation of protein localization to ciliary membrane(GO:1903568) |
| 0.1 |
0.5 |
GO:0071344 |
diphosphate metabolic process(GO:0071344) |
| 0.1 |
0.4 |
GO:0050712 |
negative regulation of interleukin-1 alpha production(GO:0032690) negative regulation of interleukin-1 alpha secretion(GO:0050712) |
| 0.1 |
0.3 |
GO:0046022 |
positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
| 0.1 |
0.5 |
GO:0006581 |
acetylcholine catabolic process in synaptic cleft(GO:0001507) acetylcholine catabolic process(GO:0006581) |
| 0.1 |
0.4 |
GO:1905167 |
positive regulation of lysosomal protein catabolic process(GO:1905167) |
| 0.1 |
0.4 |
GO:0090076 |
relaxation of skeletal muscle(GO:0090076) |
| 0.1 |
1.1 |
GO:0010991 |
negative regulation of SMAD protein complex assembly(GO:0010991) |
| 0.1 |
0.4 |
GO:2000360 |
negative regulation of binding of sperm to zona pellucida(GO:2000360) |
| 0.1 |
0.3 |
GO:1903697 |
negative regulation of microvillus assembly(GO:1903697) |
| 0.1 |
0.7 |
GO:0097411 |
hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
| 0.1 |
0.4 |
GO:0003415 |
chondrocyte hypertrophy(GO:0003415) |
| 0.1 |
0.4 |
GO:0006546 |
glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 0.1 |
0.3 |
GO:2000672 |
negative regulation of motor neuron apoptotic process(GO:2000672) |
| 0.1 |
0.2 |
GO:0035359 |
negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
| 0.1 |
1.3 |
GO:0006600 |
creatine metabolic process(GO:0006600) |
| 0.1 |
0.2 |
GO:0035408 |
histone H3-T6 phosphorylation(GO:0035408) |
| 0.1 |
0.6 |
GO:0007217 |
tachykinin receptor signaling pathway(GO:0007217) |
| 0.1 |
3.1 |
GO:0042994 |
cytoplasmic sequestering of transcription factor(GO:0042994) |
| 0.1 |
0.8 |
GO:1901731 |
positive regulation of platelet aggregation(GO:1901731) |
| 0.1 |
0.5 |
GO:2000124 |
regulation of endocannabinoid signaling pathway(GO:2000124) |
| 0.1 |
0.4 |
GO:1900145 |
regulation of nodal signaling pathway involved in determination of left/right asymmetry(GO:1900145) regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900175) |
| 0.1 |
0.9 |
GO:0000050 |
urea cycle(GO:0000050) |
| 0.1 |
0.2 |
GO:0031052 |
mesodermal-endodermal cell signaling(GO:0003131) programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) histone H2A-S139 phosphorylation(GO:0035978) positive regulation of cellular response to X-ray(GO:2000685) |
| 0.1 |
0.1 |
GO:0007351 |
tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
| 0.1 |
1.1 |
GO:0070389 |
chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.1 |
0.7 |
GO:0072656 |
maintenance of protein location in mitochondrion(GO:0072656) |
| 0.1 |
0.3 |
GO:0038098 |
sequestering of BMP from receptor via BMP binding(GO:0038098) |
| 0.1 |
0.4 |
GO:0072717 |
cellular response to actinomycin D(GO:0072717) |
| 0.1 |
0.6 |
GO:0086024 |
adrenergic receptor signaling pathway involved in positive regulation of heart rate(GO:0086024) |
| 0.1 |
0.1 |
GO:1901205 |
regulation of adrenergic receptor signaling pathway involved in heart process(GO:1901204) negative regulation of adrenergic receptor signaling pathway involved in heart process(GO:1901205) |
| 0.1 |
0.4 |
GO:0038110 |
interleukin-2-mediated signaling pathway(GO:0038110) |
| 0.1 |
0.1 |
GO:0051885 |
positive regulation of anagen(GO:0051885) |
| 0.1 |
0.4 |
GO:0072658 |
maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
| 0.1 |
1.0 |
GO:1904896 |
ESCRT complex disassembly(GO:1904896) ESCRT III complex disassembly(GO:1904903) |
| 0.1 |
0.6 |
GO:2000096 |
positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
| 0.1 |
0.3 |
GO:0060316 |
positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
| 0.1 |
0.6 |
GO:0035279 |
mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
| 0.1 |
0.1 |
GO:0097195 |
pilomotor reflex(GO:0097195) |
| 0.1 |
0.2 |
GO:0046909 |
intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
| 0.1 |
1.2 |
GO:0021756 |
striatum development(GO:0021756) |
| 0.1 |
0.4 |
GO:0010890 |
positive regulation of sequestering of triglyceride(GO:0010890) |
| 0.1 |
1.2 |
GO:0019511 |
peptidyl-proline hydroxylation(GO:0019511) |
| 0.1 |
1.0 |
GO:0015886 |
heme transport(GO:0015886) |
| 0.1 |
1.1 |
GO:0097264 |
self proteolysis(GO:0097264) |
| 0.1 |
0.1 |
GO:0061034 |
olfactory bulb mitral cell layer development(GO:0061034) |
| 0.1 |
0.4 |
GO:1903435 |
positive regulation of constitutive secretory pathway(GO:1903435) |
| 0.1 |
1.3 |
GO:0060670 |
branching involved in labyrinthine layer morphogenesis(GO:0060670) |
| 0.1 |
1.4 |
GO:0006054 |
N-acetylneuraminate metabolic process(GO:0006054) |
| 0.1 |
0.1 |
GO:0001951 |
intestinal D-glucose absorption(GO:0001951) |
| 0.1 |
1.1 |
GO:0070886 |
positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
| 0.0 |
0.2 |
GO:1903244 |
positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) positive regulation of connective tissue replacement(GO:1905205) |
| 0.0 |
0.4 |
GO:1903361 |
protein localization to basolateral plasma membrane(GO:1903361) |
| 0.0 |
0.1 |
GO:2000295 |
regulation of hydrogen peroxide catabolic process(GO:2000295) |
| 0.0 |
1.7 |
GO:0021522 |
spinal cord motor neuron differentiation(GO:0021522) |
| 0.0 |
0.2 |
GO:0042351 |
'de novo' GDP-L-fucose biosynthetic process(GO:0042351) |
| 0.0 |
0.2 |
GO:0032410 |
negative regulation of transporter activity(GO:0032410) |
| 0.0 |
0.1 |
GO:0003231 |
cardiac ventricle development(GO:0003231) |
| 0.0 |
0.1 |
GO:1900369 |
negative regulation of RNA interference(GO:1900369) |
| 0.0 |
1.0 |
GO:0071578 |
zinc II ion transmembrane import(GO:0071578) |
| 0.0 |
0.1 |
GO:0050760 |
negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
| 0.0 |
0.2 |
GO:0007509 |
mesoderm migration involved in gastrulation(GO:0007509) |
| 0.0 |
2.5 |
GO:0010811 |
positive regulation of cell-substrate adhesion(GO:0010811) |
| 0.0 |
0.1 |
GO:0070574 |
cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
| 0.0 |
0.6 |
GO:2000601 |
positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
| 0.0 |
0.4 |
GO:0070235 |
regulation of activation-induced cell death of T cells(GO:0070235) negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 0.0 |
0.2 |
GO:0030037 |
actin filament reorganization involved in cell cycle(GO:0030037) |
| 0.0 |
0.1 |
GO:0055096 |
lipoprotein particle mediated signaling(GO:0055095) low-density lipoprotein particle mediated signaling(GO:0055096) |
| 0.0 |
2.5 |
GO:0043268 |
positive regulation of potassium ion transport(GO:0043268) |
| 0.0 |
0.4 |
GO:0035965 |
cardiolipin acyl-chain remodeling(GO:0035965) |
| 0.0 |
0.2 |
GO:0061324 |
glial cell fate determination(GO:0007403) canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation(GO:0061324) regulation of chromatin-mediated maintenance of transcription(GO:1904499) positive regulation of chromatin-mediated maintenance of transcription(GO:1904501) regulation of euchromatin binding(GO:1904793) |
| 0.0 |
0.2 |
GO:0031291 |
Ran protein signal transduction(GO:0031291) |
| 0.0 |
0.2 |
GO:0070358 |
actin polymerization-dependent cell motility(GO:0070358) |
| 0.0 |
0.2 |
GO:1904044 |
response to aldosterone(GO:1904044) |
| 0.0 |
0.1 |
GO:0038043 |
interleukin-5-mediated signaling pathway(GO:0038043) |
| 0.0 |
0.1 |
GO:0072299 |
visceral serous pericardium development(GO:0061032) posterior mesonephric tubule development(GO:0072166) negative regulation of metanephric glomerulus development(GO:0072299) negative regulation of metanephric glomerular mesangial cell proliferation(GO:0072302) |
| 0.0 |
0.4 |
GO:0019344 |
cysteine biosynthetic process(GO:0019344) |
| 0.0 |
0.2 |
GO:1900104 |
hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
| 0.0 |
0.6 |
GO:0006030 |
chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
| 0.0 |
1.1 |
GO:0046339 |
diacylglycerol metabolic process(GO:0046339) |
| 0.0 |
0.4 |
GO:0016080 |
synaptic vesicle targeting(GO:0016080) |
| 0.0 |
0.3 |
GO:0034316 |
negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
| 0.0 |
0.1 |
GO:0002925 |
positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
| 0.0 |
2.5 |
GO:0030866 |
cortical actin cytoskeleton organization(GO:0030866) |
| 0.0 |
0.7 |
GO:0045008 |
depyrimidination(GO:0045008) |
| 0.0 |
0.2 |
GO:0051967 |
negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
| 0.0 |
0.1 |
GO:0090206 |
negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
| 0.0 |
0.4 |
GO:0006568 |
tryptophan metabolic process(GO:0006568) |
| 0.0 |
0.3 |
GO:0038003 |
opioid receptor signaling pathway(GO:0038003) |
| 0.0 |
0.3 |
GO:0018344 |
protein geranylgeranylation(GO:0018344) |
| 0.0 |
0.6 |
GO:1904714 |
regulation of chaperone-mediated autophagy(GO:1904714) |
| 0.0 |
0.2 |
GO:0019303 |
D-ribose catabolic process(GO:0019303) |
| 0.0 |
0.9 |
GO:0045332 |
phospholipid translocation(GO:0045332) |
| 0.0 |
0.4 |
GO:0032776 |
DNA methylation on cytosine(GO:0032776) |
| 0.0 |
0.3 |
GO:0042985 |
negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
| 0.0 |
0.1 |
GO:0072255 |
metanephric glomerular mesangial cell development(GO:0072255) reversible differentiation(GO:0090677) cell dedifferentiation involved in phenotypic switching(GO:0090678) positive regulation of phenotypic switching(GO:1900241) regulation of vascular smooth muscle cell dedifferentiation(GO:1905174) positive regulation of vascular smooth muscle cell dedifferentiation(GO:1905176) vascular smooth muscle cell dedifferentiation(GO:1990936) |
| 0.0 |
0.3 |
GO:0042246 |
tissue regeneration(GO:0042246) |
| 0.0 |
0.1 |
GO:2001023 |
regulation of response to drug(GO:2001023) |
| 0.0 |
0.3 |
GO:2001206 |
positive regulation of osteoclast development(GO:2001206) |
| 0.0 |
0.1 |
GO:0060372 |
regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) |
| 0.0 |
0.1 |
GO:0030968 |
endoplasmic reticulum unfolded protein response(GO:0030968) cellular response to unfolded protein(GO:0034620) cellular response to topologically incorrect protein(GO:0035967) |
| 0.0 |
0.1 |
GO:2001226 |
negative regulation of chloride transport(GO:2001226) |
| 0.0 |
1.4 |
GO:2000772 |
regulation of cellular senescence(GO:2000772) |
| 0.0 |
0.2 |
GO:0090309 |
positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
| 0.0 |
0.1 |
GO:1901842 |
negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
| 0.0 |
0.1 |
GO:0014740 |
negative regulation of muscle hyperplasia(GO:0014740) |
| 0.0 |
0.1 |
GO:0021631 |
optic nerve morphogenesis(GO:0021631) |
| 0.0 |
1.5 |
GO:0090200 |
positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
| 0.0 |
0.2 |
GO:0070669 |
response to interleukin-2(GO:0070669) |
| 0.0 |
0.2 |
GO:0035672 |
oligopeptide transmembrane transport(GO:0035672) |
| 0.0 |
0.1 |
GO:0071279 |
cellular response to cobalt ion(GO:0071279) |
| 0.0 |
0.7 |
GO:0019370 |
leukotriene biosynthetic process(GO:0019370) |
| 0.0 |
0.1 |
GO:0030070 |
insulin processing(GO:0030070) |
| 0.0 |
0.2 |
GO:0006196 |
AMP catabolic process(GO:0006196) |
| 0.0 |
0.1 |
GO:1904479 |
negative regulation of intestinal absorption(GO:1904479) |
| 0.0 |
0.2 |
GO:0061143 |
alveolar primary septum development(GO:0061143) |
| 0.0 |
0.2 |
GO:0060158 |
phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 0.0 |
0.1 |
GO:0044336 |
canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
| 0.0 |
0.1 |
GO:0001831 |
trophectodermal cellular morphogenesis(GO:0001831) |
| 0.0 |
0.1 |
GO:1903028 |
positive regulation of opsonization(GO:1903028) |
| 0.0 |
0.6 |
GO:0072189 |
ureter development(GO:0072189) |
| 0.0 |
0.4 |
GO:0030043 |
actin filament fragmentation(GO:0030043) |
| 0.0 |
0.1 |
GO:0003335 |
corneocyte development(GO:0003335) |
| 0.0 |
1.3 |
GO:0007274 |
neuromuscular synaptic transmission(GO:0007274) |
| 0.0 |
0.1 |
GO:1905154 |
negative regulation of membrane invagination(GO:1905154) |
| 0.0 |
0.4 |
GO:0071688 |
striated muscle myosin thick filament assembly(GO:0071688) |
| 0.0 |
0.2 |
GO:2000491 |
positive regulation of hepatic stellate cell activation(GO:2000491) |
| 0.0 |
0.4 |
GO:0014029 |
neural crest formation(GO:0014029) |
| 0.0 |
0.2 |
GO:0051418 |
interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
| 0.0 |
0.1 |
GO:2000721 |
positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
| 0.0 |
1.9 |
GO:0050885 |
neuromuscular process controlling balance(GO:0050885) |
| 0.0 |
0.3 |
GO:1903608 |
protein localization to cytoplasmic stress granule(GO:1903608) |
| 0.0 |
0.1 |
GO:0016259 |
selenocysteine metabolic process(GO:0016259) |
| 0.0 |
0.1 |
GO:0021510 |
spinal cord development(GO:0021510) |
| 0.0 |
0.1 |
GO:0010734 |
protein glutathionylation(GO:0010731) regulation of protein glutathionylation(GO:0010732) negative regulation of protein glutathionylation(GO:0010734) regulation of sodium ion export(GO:1903273) positive regulation of sodium ion export(GO:1903275) regulation of sodium ion export from cell(GO:1903276) positive regulation of sodium ion export from cell(GO:1903278) |
| 0.0 |
0.2 |
GO:0001778 |
plasma membrane repair(GO:0001778) |
| 0.0 |
0.2 |
GO:0031444 |
slow-twitch skeletal muscle fiber contraction(GO:0031444) |
| 0.0 |
0.6 |
GO:0032486 |
Rap protein signal transduction(GO:0032486) |
| 0.0 |
0.6 |
GO:0097120 |
receptor localization to synapse(GO:0097120) |
| 0.0 |
0.0 |
GO:0048294 |
negative regulation of isotype switching to IgE isotypes(GO:0048294) |
| 0.0 |
0.1 |
GO:2000490 |
negative regulation of hepatic stellate cell activation(GO:2000490) |
| 0.0 |
1.4 |
GO:0035987 |
endodermal cell differentiation(GO:0035987) |
| 0.0 |
0.1 |
GO:0070844 |
misfolded protein transport(GO:0070843) polyubiquitinated protein transport(GO:0070844) polyubiquitinated misfolded protein transport(GO:0070845) Hsp90 deacetylation(GO:0070846) |
| 0.0 |
0.2 |
GO:0006686 |
sphingomyelin biosynthetic process(GO:0006686) |
| 0.0 |
0.1 |
GO:0034393 |
positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
| 0.0 |
0.1 |
GO:0071205 |
protein localization to juxtaparanode region of axon(GO:0071205) |
| 0.0 |
0.4 |
GO:1903351 |
response to dopamine(GO:1903350) cellular response to dopamine(GO:1903351) |
| 0.0 |
0.2 |
GO:0034551 |
respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
| 0.0 |
0.4 |
GO:0039532 |
negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway(GO:0039532) |
| 0.0 |
0.2 |
GO:1903012 |
positive regulation of bone development(GO:1903012) |
| 0.0 |
0.1 |
GO:0035262 |
gonad morphogenesis(GO:0035262) |
| 0.0 |
0.6 |
GO:0016180 |
snRNA processing(GO:0016180) |
| 0.0 |
0.1 |
GO:0021764 |
amygdala development(GO:0021764) |
| 0.0 |
0.1 |
GO:1902474 |
regulation of protein localization to synapse(GO:1902473) positive regulation of protein localization to synapse(GO:1902474) |
| 0.0 |
0.3 |
GO:0070234 |
positive regulation of T cell apoptotic process(GO:0070234) |
| 0.0 |
0.1 |
GO:0000415 |
negative regulation of histone H3-K36 methylation(GO:0000415) |
| 0.0 |
0.1 |
GO:0007406 |
negative regulation of neuroblast proliferation(GO:0007406) |
| 0.0 |
0.1 |
GO:1904298 |
positive regulation of neutrophil degranulation(GO:0043315) cellular response to gravity(GO:0071258) positive regulation of neutrophil activation(GO:1902565) positive regulation of sensory perception of pain(GO:1904058) regulation of transcytosis(GO:1904298) positive regulation of transcytosis(GO:1904300) regulation of maternal process involved in parturition(GO:1904301) positive regulation of maternal process involved in parturition(GO:1904303) response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904316) cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904317) |
| 0.0 |
0.4 |
GO:0097034 |
mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
| 0.0 |
0.1 |
GO:0019065 |
receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
| 0.0 |
0.9 |
GO:0097435 |
fibril organization(GO:0097435) |
| 0.0 |
0.2 |
GO:0043569 |
negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
| 0.0 |
0.1 |
GO:0001544 |
initiation of primordial ovarian follicle growth(GO:0001544) |
| 0.0 |
0.4 |
GO:0006473 |
protein acetylation(GO:0006473) |
| 0.0 |
0.2 |
GO:0022401 |
desensitization of G-protein coupled receptor protein signaling pathway(GO:0002029) negative adaptation of signaling pathway(GO:0022401) |
| 0.0 |
0.2 |
GO:0061732 |
mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
| 0.0 |
0.2 |
GO:0071028 |
nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
| 0.0 |
0.1 |
GO:0044313 |
protein K6-linked deubiquitination(GO:0044313) |
| 0.0 |
0.0 |
GO:0009183 |
purine deoxyribonucleoside diphosphate biosynthetic process(GO:0009183) |
| 0.0 |
0.1 |
GO:1904448 |
negative regulation of gamma-aminobutyric acid secretion(GO:0014053) negative regulation of dopamine secretion(GO:0033602) aspartate secretion(GO:0061528) regulation of aspartate secretion(GO:1904448) positive regulation of aspartate secretion(GO:1904450) |
| 0.0 |
2.9 |
GO:0006805 |
xenobiotic metabolic process(GO:0006805) |
| 0.0 |
0.0 |
GO:0010915 |
regulation of very-low-density lipoprotein particle clearance(GO:0010915) negative regulation of very-low-density lipoprotein particle clearance(GO:0010916) |
| 0.0 |
0.1 |
GO:0007388 |
anterior compartment pattern formation(GO:0007387) posterior compartment specification(GO:0007388) |
| 0.0 |
0.4 |
GO:0050901 |
leukocyte tethering or rolling(GO:0050901) |
| 0.0 |
0.4 |
GO:1904886 |
beta-catenin destruction complex disassembly(GO:1904886) |
| 0.0 |
0.1 |
GO:0014055 |
acetylcholine secretion, neurotransmission(GO:0014055) regulation of acetylcholine secretion, neurotransmission(GO:0014056) positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
| 0.0 |
0.7 |
GO:0045494 |
photoreceptor cell maintenance(GO:0045494) |
| 0.0 |
0.7 |
GO:0006198 |
cAMP catabolic process(GO:0006198) |
| 0.0 |
0.7 |
GO:0030517 |
negative regulation of axon extension(GO:0030517) |
| 0.0 |
0.2 |
GO:0032020 |
ISG15-protein conjugation(GO:0032020) |
| 0.0 |
0.7 |
GO:0060384 |
innervation(GO:0060384) |
| 0.0 |
1.6 |
GO:0016266 |
O-glycan processing(GO:0016266) |
| 0.0 |
0.2 |
GO:0038028 |
insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
| 0.0 |
0.1 |
GO:0010587 |
miRNA catabolic process(GO:0010587) |
| 0.0 |
0.0 |
GO:0060629 |
regulation of homologous chromosome segregation(GO:0060629) |
| 0.0 |
0.2 |
GO:0070585 |
protein localization to mitochondrion(GO:0070585) |
| 0.0 |
1.6 |
GO:0006958 |
complement activation, classical pathway(GO:0006958) |
| 0.0 |
0.0 |
GO:0080120 |
CAAX-box protein processing(GO:0071586) CAAX-box protein maturation(GO:0080120) |
| 0.0 |
0.3 |
GO:0045717 |
negative regulation of fatty acid biosynthetic process(GO:0045717) |
| 0.0 |
0.3 |
GO:0050851 |
antigen receptor-mediated signaling pathway(GO:0050851) |
| 0.0 |
0.1 |
GO:0015772 |
disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 0.0 |
0.1 |
GO:0072553 |
terminal button organization(GO:0072553) |
| 0.0 |
0.1 |
GO:0070124 |
mitochondrial translational initiation(GO:0070124) |
| 0.0 |
0.2 |
GO:0015705 |
iodide transport(GO:0015705) |
| 0.0 |
0.0 |
GO:1900126 |
negative regulation of hyaluronan biosynthetic process(GO:1900126) |
| 0.0 |
0.3 |
GO:1904355 |
positive regulation of telomere capping(GO:1904355) |
| 0.0 |
0.1 |
GO:0071233 |
cellular response to leucine(GO:0071233) |
| 0.0 |
0.6 |
GO:0035728 |
response to hepatocyte growth factor(GO:0035728) |
| 0.0 |
0.1 |
GO:0003322 |
pancreatic A cell development(GO:0003322) |
| 0.0 |
0.1 |
GO:0099624 |
atrial cardiac muscle cell membrane repolarization(GO:0099624) |
| 0.0 |
0.5 |
GO:0010573 |
vascular endothelial growth factor production(GO:0010573) regulation of vascular endothelial growth factor production(GO:0010574) |
| 0.0 |
1.1 |
GO:0007566 |
embryo implantation(GO:0007566) |
| 0.0 |
0.4 |
GO:0050667 |
homocysteine metabolic process(GO:0050667) |
| 0.0 |
0.1 |
GO:0002290 |
gamma-delta T cell activation involved in immune response(GO:0002290) negative regulation of serotonin secretion(GO:0014063) negative regulation of interferon-beta secretion(GO:0035548) regulation of gamma-delta T cell activation involved in immune response(GO:2001191) positive regulation of gamma-delta T cell activation involved in immune response(GO:2001193) negative regulation of transforming growth factor-beta secretion(GO:2001202) |
| 0.0 |
0.2 |
GO:0002051 |
osteoblast fate commitment(GO:0002051) |
| 0.0 |
0.4 |
GO:0032292 |
myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
| 0.0 |
0.1 |
GO:0006741 |
NADP biosynthetic process(GO:0006741) |
| 0.0 |
0.5 |
GO:0050855 |
regulation of B cell receptor signaling pathway(GO:0050855) |
| 0.0 |
0.4 |
GO:0036151 |
phosphatidylcholine acyl-chain remodeling(GO:0036151) |
| 0.0 |
1.3 |
GO:0006501 |
C-terminal protein lipidation(GO:0006501) |
| 0.0 |
0.1 |
GO:0048488 |
synaptic vesicle endocytosis(GO:0048488) |
| 0.0 |
0.9 |
GO:0000381 |
regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
| 0.0 |
0.1 |
GO:0009597 |
detection of virus(GO:0009597) |
| 0.0 |
0.1 |
GO:0032688 |
negative regulation of interferon-beta production(GO:0032688) |
| 0.0 |
0.0 |
GO:1904529 |
regulation of actin filament binding(GO:1904529) negative regulation of actin filament binding(GO:1904530) regulation of actin binding(GO:1904616) negative regulation of actin binding(GO:1904617) |
| 0.0 |
0.2 |
GO:0044872 |
lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
| 0.0 |
0.1 |
GO:1901552 |
positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
| 0.0 |
0.4 |
GO:0032012 |
regulation of ARF protein signal transduction(GO:0032012) |
| 0.0 |
0.0 |
GO:0034553 |
respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
| 0.0 |
0.1 |
GO:1904721 |
negative regulation of mRNA cleavage(GO:0031438) negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904721) |
| 0.0 |
0.2 |
GO:0046500 |
S-adenosylmethionine metabolic process(GO:0046500) |
| 0.0 |
0.1 |
GO:0061368 |
behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
| 0.0 |
0.5 |
GO:2000300 |
regulation of synaptic vesicle exocytosis(GO:2000300) |
| 0.0 |
0.2 |
GO:0051451 |
myoblast migration(GO:0051451) |
| 0.0 |
0.3 |
GO:0016254 |
preassembly of GPI anchor in ER membrane(GO:0016254) |
| 0.0 |
0.1 |
GO:0051170 |
nuclear import(GO:0051170) |
| 0.0 |
0.1 |
GO:0009957 |
epidermal cell fate specification(GO:0009957) |
| 0.0 |
0.2 |
GO:0071447 |
cellular response to hydroperoxide(GO:0071447) |
| 0.0 |
0.1 |
GO:0042167 |
porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
| 0.0 |
0.1 |
GO:0010816 |
substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
| 0.0 |
0.1 |
GO:0042797 |
5S class rRNA transcription from RNA polymerase III type 1 promoter(GO:0042791) tRNA transcription from RNA polymerase III promoter(GO:0042797) |
| 0.0 |
0.6 |
GO:0015914 |
phospholipid transport(GO:0015914) |
| 0.0 |
0.5 |
GO:0035456 |
response to interferon-beta(GO:0035456) |
| 0.0 |
0.2 |
GO:0006554 |
lysine catabolic process(GO:0006554) |
| 0.0 |
0.1 |
GO:0032888 |
regulation of spindle elongation(GO:0032887) regulation of mitotic spindle elongation(GO:0032888) anastral spindle assembly(GO:0055048) protein localization to spindle pole body(GO:0071988) regulation of protein localization to spindle pole body(GO:1902363) positive regulation of protein localization to spindle pole body(GO:1902365) positive regulation of mitotic spindle elongation(GO:1902846) |
| 0.0 |
0.1 |
GO:0038165 |
oncostatin-M-mediated signaling pathway(GO:0038165) |
| 0.0 |
0.1 |
GO:0061635 |
regulation of protein complex stability(GO:0061635) |
| 0.0 |
0.2 |
GO:0006307 |
DNA dealkylation involved in DNA repair(GO:0006307) |
| 0.0 |
0.7 |
GO:0050690 |
regulation of defense response to virus by virus(GO:0050690) |
| 0.0 |
0.1 |
GO:0016998 |
cell wall macromolecule catabolic process(GO:0016998) |
| 0.0 |
0.2 |
GO:0007175 |
negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
